Search by Drug Name or NDC

    NDC 61314-0476-64 HYRIMOZ 20 mg/.2mL Details

    HYRIMOZ 20 mg/.2mL

    HYRIMOZ is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is ADALIMUMAB.

    Product Information

    NDC 61314-0476
    Product ID 61314-476_5f7d6cf0-6300-4c73-a848-e9da6adf1680
    Associated GPIs
    GCN Sequence Number 084549
    GCN Sequence Number Description adalimumab-adaz SYRINGE 20MG/0.2ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 53883
    HICL Sequence Number 045444
    HICL Sequence Number Description ADALIMUMAB-ADAZ
    Brand/Generic Brand
    Proprietary Name HYRIMOZ
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-adaz
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/.2mL
    Substance Name ADALIMUMAB
    Labeler Name Sandoz Inc
    Pharmaceutical Class Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761071
    Listing Certified Through 2024-12-31

    Package

    NDC 61314-0476-64 (61314047664)

    NDC Package Code 61314-476-64
    Billing NDC 61314047664
    Package 2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-07-01
    NDC Exclude Flag N
    Pricing Information N/A